Ms Menekse Turna – Radiation Oncology – Best Researcher Award

Ms Menekse Turna - Radiation Oncology - Best Researcher Award

Anadolu Medical Center - Turkey

AUTHOR PROFILE

Orchid

Scopus

Early Academic Pursuits

Menekşe Turna began her academic journey with a strong foundation at the Karadeniz Technical University Faculty Of Medicine in Trabzon, Turkey, where she dedicated six years of study from 2005 to 2011. This period laid the groundwork for her future contributions in the field of medicine.

Professional Endeavors

Upon completing her medical education, Menekşe Turna delved into the specialized field of Radiation Oncology. She started her professional journey at Okmeydani Research and Training Hospital in Istanbul, where she gained valuable experience from 2012 to 2016. Later, she expanded her horizons by joining the St James Institute of Oncology in Leeds, England, as a Clinical Observer in 2015-2016, further enriching her knowledge in the international medical landscape.

Contributions and Research Focus on Radiation oncology

Menekşe Turna's primary focus in Radiation Oncology showcases her commitment to advancing cancer treatment. Her contributions to the field involve a keen interest in therapeutic radiology, emphasizing precision and efficacy in cancer treatment methods. Through her work, she aims to contribute to the ongoing advancements in radiation therapy for improved patient outcomes.

Academic Cites

Menekşe Turna's academic achievements are reflected in her successful completion of the Second degree in the Board Exam of the Turkish Society for Radiation Oncology in 2016. This recognition signifies her expertise and proficiency in the field.

Legacy and Future Contributions

As a dedicated medical professional, Menekşe Turna is already leaving a positive mark on the field of Radiation Oncology. Her legacy lies in the lives she impacts through precise and compassionate cancer care. Looking forward, she envisions continued contributions to research, education, and patient care, leaving an enduring legacy in the medical community.

NOTABLE PUBLICATIONS

Stereotactic radiosurgery in brain metastasis: treatment outcomes and patterns of failure.2023

Evaluation of clinically involved lymph nodes with deformable registration in breast cancer radiotherapy.2022

Stereotactic body radiotherapy as a boost after external beam radiotherapy for high-risk prostate cancer patients.2021

 

Visionary in Oncology and Cancer Research Award

Introduction: Step into the future of oncology research with the Visionary in Oncology and Cancer Research Award. This distinguished accolade recognizes those who dare to push boundaries, bringing transformative vision to the fight against cancer.

Award Eligibility: Open to global visionaries, this award is not bound by age limits. To qualify, candidates must hold a doctoral degree, boast a stellar publication record, and demonstrate a visionary approach to oncology research.

Evaluation Criteria: Candidates will be assessed based on the visionary nature of their research, the impact of their publications, and their ability to redefine the landscape of cancer research. Awardees should exemplify a commitment to innovative thinking and groundbreaking contributions.

Submission Guidelines: Nominees are encouraged to submit a comprehensive biography, an abstract outlining their visionary research, and supporting files that underscore the transformative nature of their work. Submissions should strictly adhere to the specified format guidelines.

Recognition and Community Impact: Beyond individual recognition, this award celebrates the broader impact of the recipient's visionary approach on the global oncology community. Awardees will be acknowledged in high-profile events and publications, amplifying the influence of their groundbreaking work.